# To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence

> **NCT06360523** · NA · RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 368 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** AI modal
- **DIAGNOSTIC_TEST:** Standard review

## Key facts

- **NCT ID:** NCT06360523
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-14
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 368 (ESTIMATED)
- **Last updated:** 2025-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06360523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06360523, "To Evaluate an MRI-based Optimized Prostate Cancer Diagnostic Pathway Powered by Artificial Intelligence". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06360523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*